Multi-omic subtyping and molecular determinants of neoadjuvant therapeutic regimen for locally advanced HER2-positive and triple-negative breast cancer: Implications of novel therapy.
Max Planck researchers have for the first time analyzed the frequency of molecular resonance, in the same way as musicians analyze the notes of a chord. Their results have even been made audible. In ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results